RecruitingNot ApplicableNCT06307574

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications

Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment

Sponsor

University of Arizona

Enrollment

100 participants

Start Date

Feb 29, 2024

Study Type

INTERVENTIONAL

Conditions

Hypertension Aging Mild Cognitive Impairment

Summary

The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.

Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a digital app called bpMedManage can help older adults with mild memory or thinking challenges remember to take their blood pressure medications and better manage their hypertension at home. **You may be eligible if...** - You are 60 years or older and live in the community (not in a care facility) - You self-manage at least one prescribed blood pressure medication - You have a smartphone and are willing to use it - You have mild self-reported memory or thinking challenges - Your cognitive screening scores fall within a specific range (TICS-M 27–37, MoCA 20–26) - You are fluent in English **You may NOT be eligible if...** - You have been diagnosed with dementia or a neurological condition like Parkinson's disease, stroke, or traumatic brain injury - You live in an assisted living or skilled nursing facility - You have a history of major depression or other mental health diagnoses - You do not have a smartphone Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALbpMedManage

In this 16-week RCT, a total of 100 older adults with MCI will be recruited. There are two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.